Related Experiment Video
Updated: Jul 25, 2025

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability
Published on: July 12, 2024
Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
Atefeh Malek-Khatabi1, Malihe Sadat Razavi2,3, Alyeh Abdollahi1
1Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Polymeric microneedles (MNs) offer minimally invasive delivery of drugs and vaccines by bypassing the skin barrier. This review highlights advances in polylactic glycolic acid (PLGA)-based MNs, covering their types, applications, and future prospects.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Pharmaceutical Sciences
Background:
- Microneedles (MNs) are advanced delivery systems that enable minimally invasive transdermal and intradermal administration.
- Polymeric MN arrays, particularly those made from polylactic glycolic acid (PLGA), are gaining prominence due to their biocompatibility and biodegradability.
- PLGA is an FDA-approved copolymer, making PLGA-based MNs a safe and effective option for therapeutic delivery.
Purpose of the Study:
- To review the latest advancements in polylactic glycolic acid (PLGA)-based microneedle (MN) technology.
- To discuss both PLGA nanoparticle-based and PLGA matrix-based MNs for various therapeutic applications.
- To explore the diverse types of MNs and their potential uses, alongside future challenges and opportunities.
Main Methods:
- Literature review of recent studies on PLGA-based microneedles.
- Analysis of different fabrication methods for PLGA MNs (nanoparticle-based and matrix-based).
- Synthesis of information on applications in drug, vaccine, and protein delivery.
Main Results:
- PLGA-based MNs demonstrate significant potential for enhanced drug and vaccine delivery by overcoming the stratum corneum barrier.
- Both nanoparticle and matrix-based PLGA MNs are effective carriers for various therapeutic agents.
- A wide range of applications for PLGA MNs are emerging, including targeted intradermal delivery.
Conclusions:
- PLGA-based microneedles represent a promising frontier in transdermal and intradermal delivery systems.
- Continued research into PLGA MNs is essential to overcome existing challenges and fully realize their therapeutic potential.
- The biocompatibility and biodegradability of PLGA support its use in innovative MN delivery platforms.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

